ACS    Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction Eur Heart J (2009) 30; 549-57 J. A. Wong, S. G. Goodman, R. T. Yan, R. Wald, A. J. Bagnall, R. C. Welsh, G. C. Wong, J. Kornder, K. A. Eagle, P. G. Steg and A. T. Yan Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry Am Heart J (2008) 155; 361-8 T. Y. Wang, L. A. Robinson, F. S. Ou, M. T. Roe, E. M. Ohman, W. B. Gibler, S. C. Smith, Jr., E. D. Peterson and R. C. Becker Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiative Eur Heart J (2008) 29; 1103-9 T. Y. Wang, A. Y. Chen, E. D. Peterson, R. C. Becker, W. B. Gibler, E. M. Ohman and M. T. Roe Acute coronary syndrome in the elderly Eur Heart J (2008) 29; 1213-4 C. J. Vrints 9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study J Am Coll Cardiol (2009) 53; 1031-9 S. Verheye, P. Agostoni, C. L. Dubois, J. Dens, J. Ormiston, S. Worthley, B. Trauthen, T. Hasegawa, B. K. Koo, P. J. Fitzgerald, R. Mehran and A. J. Lansky Prognostic value of free plasma homocysteine levels in patients hospitalized with acute coronary syndrome Am J Cardiol (2008) 102; 135-9 M. G. van Oijen, B. E. Claessen, N. Clappers, A. van Schaik, R. J. Laheij, J. B. Jansen, W. H. Peters and F. W. Verheugt Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndrome Eur Heart J (2008) 29; 2713-22 D. N. Tziakas, G. K. Chalikias, I. K. Tentes, D. Stakos, S. V. Chatzikyriakou, K. Mitrousi, A. X. Kortsaris, J. C. Kaski and H. Boudoulas Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study) Am J Cardiol (2009) 103; 577-82 M. J. Tikkanen, I. Holme, N. B. Cater, M. Szarek, O. Faergeman, J. J. Kastelein, A. G. Olsson, M. L. Larsen, C. Lindahl and T. R. Pedersen Usefulness of persistent symptoms of depression to predict physical health status 12 months after an acute coronary syndrome Am J Cardiol (2008) 101; 15-9 B. D. Thombs, R. C. Ziegelstein, D. E. Stewart, S. E. Abbey, K. Parakh and S. L. Grace Long-term benefit of postconditioning Circulation (2008) 117; 1037-44 H. Thibault, C. Piot, P. Staat, L. Bontemps, C. Sportouch, G. Rioufol, T. T. Cung, E. Bonnefoy, D. Angoulvant, J. F. Aupetit, G. Finet, X. Andre-Fouet, J. C. Macia, F. Raczka, R. Rossi, R. Itti, G. Kirkorian, G. Derumeaux and M. Ovize Temporal course of pregnancy-associated plasma protein-A in angioplasty-treated ST-elevation myocardial infarction patients and potential significance of concomitant heparin administration Am J Cardiol (2009) 103; 29-35 C. J. Terkelsen, C. Oxvig, B. L. Norgaard, S. Glerup, T. S. Poulsen, J. F. Lassen, H. J. Moller, L. Thuesen, E. Falk, T. T. Nielsen and H. R. Andersen Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial Lancet (2008) 371; 1761-8 J. C. Tardif, J. J. McMurray, E. Klug, R. Small, J. Schumi, J. Choi, J. Cooper, R. Scott, E. F. Lewis, P. L. L'Allier and M. A. Pfeffer Relationship between longitudinal morphology of ruptured plaques and TIMI flow grade in acute coronary syndrome: a three-dimensional intravascular ultrasound imaging study Eur Heart J (2008) 29; 38-44 A. Tanaka, K. Shimada, M. Namba, T. Sakamoto, Y. Nakamura, Y. Nishida, J. Yoshikawa and T. Akasaka Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes Am J Cardiol (2009) 103; 187-93 C. Tamburino, M. E. Di Salvo, D. Capodanno, T. Palmerini, I. Sheiban, M. Margheri, G. Vecchi, G. Sangiorgi, G. Piovaccari, A. Bartorelli, C. Briguori, D. Ardissino, F. Di Pede, A. Ramondo, L. Inglese, A. S. Petronio, L. Bolognese, A. Benassi, C. Palmieri, V. Filippone and S. De Servi Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial) Am J Cardiol (2009) 103; 785-90 N. Taglieri, F. Saia, V. Guiducci, S. Tondi, F. Conrotto, C. Marrozzini, G. Rocchi, E. Biagini, M. L. Reggiani, P. Giacometti, G. Piovaccari, A. Manari and A. Marzocchi Delay to angiography and outcomes following presentation with high-risk, non-ST-elevation acute coronary syndromes: results from the Global Registry of Acute Coronary Events Heart (2009) 95; 211-5 N. Swanson, G. Montalescot, K. A. Eagle, S. G. Goodman, W. Huang, D. Brieger and G. Devlin Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trials Eur Heart J (2009) E. Swahn, J. Alfredsson, R. Afzal, A. Budaj, S. Chrolavicius, K. Fox, S. Jolly, S. R. Mehta, R. de Winter and S. Yusuf Clopidogrel in acute coronary syndrome: to genotype or not? Lancet (2009) 373; 276-8 R. F. Storey Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells Eur Heart J (2009) 30; 584-93 K. Stellos, B. Bigalke, H. Langer, T. Geisler, A. Schad, A. Kogel, F. Pfaff, D. Stakos, P. Seizer, I. Muller, P. Htun, S. Lindemann and M. Gawaz Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents Am J Cardiol (2009) 103; 491-5 D. H. Steinberg, M. A. Gaglia, Jr., T. L. Pinto Slottow, P. Roy, L. Bonello, A. De Labriolle, G. Lemesle, R. Torguson, K. Kineshige, Z. Xue, W. O. Suddath, K. M. Kent, L. F. Satler, A. D. Pichard, J. Lindsay and R. Waksman Prognostic implications of normal (<0.10 ng/ml) and borderline (0.10 to 1.49 ng/ml) troponin elevation levels in critically ill patients without acute coronary syndrome Am J Cardiol (2008) 102; 509-12 R. Stein, B. Gupta, S. Agarwal, J. Golub, D. Bhutani, A. Rosman and C. Eng Evolving applications for patient-centered health status measures Circulation (2008) 118; 2103-10 J. A. Spertus Acute vessel occlusion after coronary stenting: intravascular ultrasound diagnosis of extensive intramural haematoma Eur Heart J (2008) 29; 9 G. Souteyrand and P. Motreff Effect of prehospital triage on revascularization times, left ventricular function, and survival in patients with ST-elevation myocardial infarction Am J Cardiol (2009) 103; 907-12 G. Sivagangabalan, A. T. Ong, A. Narayan, N. Sadick, P. S. Hansen, G. C. Nelson, M. Flynn, D. L. Ross, S. C. Boyages and P. Kovoor Outcomes and quality of life in patients>or=85 years of age with ST-elevation myocardial infarction Am J Cardiol (2009) 103; 170-4 P. Shah, A. H. Najafi, J. A. Panza and H. A. Cooper Arterial access-site-related outcomes of patients undergoing invasive coronary procedures for acute coronary syndromes (from the ComPaRison of Early Invasive and Conservative Treatment in Patients With Non-ST-ElevatiOn Acute Coronary Syndromes [PRESTO-ACS] Vascular Substudy) Am J Cardiol (2009) 103; 796-800 A. Sciahbasi, C. Pristipino, G. Ambrosio, I. Sperduti, E. V. Scabbia, C. Greco, R. Ricci, G. Ferraiolo, D. Di Clemente, C. Giombolini, E. Lioy and M. Tubaro Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D) Am J Cardiol (2009) 103; 632-8 L. Schwartz, K. E. Kip, E. Alderman, J. Lu, E. R. Bates, V. Srinivas, R. G. Bach, L. D. Mighton, F. Feit, S. King, 3rd and R. L. Frye Long-term outcome of prophylactic coronary revascularization in cardiac high-risk patients undergoing major vascular surgery (from the randomized DECREASE-V Pilot Study) Am J Cardiol (2009) 103; 897-901 O. Schouten, J. P. van Kuijk, W. J. Flu, T. A. Winkel, G. M. Welten, E. Boersma, H. J. Verhagen, J. J. Bax and D. Poldermans Feasibility of combined use of intravascular ultrasound radiofrequency data analysis and optical coherence tomography for detecting thin-cap fibroatheroma Eur Heart J (2008) 29; 1136-46 T. Sawada, J. Shite, H. M. Garcia-Garcia, T. Shinke, S. Watanabe, H. Otake, D. Matsumoto, Y. Tanino, D. Ogasawara, H. Kawamori, H. Kato, N. Miyoshi, M. Yokoyama, P. W. Serruys and K. Hirata Once-a-week rosuvastatin (2.5 to 20 mg) in patients with a previous statin intolerance Am J Cardiol (2009) 103; 393-4 J. F. Ruisinger, J. M. Backes, C. A. Gibson and P. M. Moriarty Requirement for emergent coronary artery bypass surgery following percutaneous coronary intervention in the stent era Am J Cardiol (2009) 103; 950-3 P. Roy, A. de Labriolle, N. Hanna, L. Bonello, T. Okabe, T. L. Pinto Slottow, D. H. Steinberg, R. Torguson, K. Kaneshige, Z. Xue, L. F. Satler, K. M. Kent, W. O. Suddath, A. D. Pichard, J. Lindsay and R. Waksman Platelet glycoprotein IIb/IIIa receptor inhibitors--end of an era? Eur Heart J (2008) 29; 429-31 M. Roffi and D. Mukherjee Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromes Eur Heart J (2008) 29; 2480-8 M. T. Roe, F. S. Ou, K. P. Alexander, L. K. Newby, J. M. Foody, W. B. Gibler, W. E. Boden, E. M. Ohman, S. C. Smith, Jr. and E. D. Peterson Immediate versus deferred coronary angioplasty in non-ST-elevation acute coronary syndromes Heart (2008) R. K. Riezebos, E. Ronner, E. Ter Bals, T. Slagboom, P. C. Smits, J. M. Ten Berg, F. Kiemeneij, G. Amoroso, M. S. Patterson, M. J. Suttorp, J. G. Tijssen and G. J. Laarman Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event Am J Cardiol (2009) 103; 437-41 R. Rawlings, A. Nohria, P. Y. Liu, J. Donnelly, M. A. Creager, P. Ganz, A. Selwyn and J. K. Liao Intimal hyperplasia and cystic medial necrosis as substrate of acute coronary syndrome in a cocaine abuser: an in vivo/ex vivo pathological correlation Heart (2009) 95; 82 A. B. Ramondo, F. Mistrorigo and A. Angelini Effect of beta blockers (metoprolol or propranolol) on effect of simvastatin in lowering C-reactive protein in acute myocardial infarction Am J Cardiol (2009) 103; 461-3 J. C. Quinaglia e Silva, D. B. Munhoz, T. N. Morato, A. Gurgel, A. C. Macedo, P. Sever and A. C. Sposito Evaluation of plaque characteristics in acute coronary syndromes: non-invasive assessment with multi-slice computed tomography and invasive evaluation with intravascular ultrasound radiofrequency data analysis Eur Heart J (2008) 29; 2373-81 G. Pundziute, J. D. Schuijf, J. W. Jukema, I. Decramer, G. Sarno, P. K. Vanhoenacker, E. Boersma, J. H. Reiber, M. J. Schalij, W. Wijns and J. J. Bax Noninvasive assessment of coronary in-stent restenosis by dual-source computed tomography Am J Cardiol (2009) 103; 812-7 T. Pflederer, M. Marwan, A. Renz, S. Bachmann, D. Ropers, A. Kuettner, K. Anders, F. Bamberg, W. G. Daniel and S. Achenbach Initial assessment of clinical impact of a drug interaction between clopidogrel and proton pump inhibitors J Am Coll Cardiol (2008) 52; 1038-9; author reply 39 E. Pezalla, D. Day and I. Pulliadath Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study) Am J Cardiol (2009) 103; 181-6 M. R. Patel, M. E. Pfisterer, A. Betriu, P. Widmisky, D. R. Holmes, Jr., W. W. O'Neill, A. Stebbins, F. Van de Werf, P. W. Armstrong and C. B. Granger Effectiveness of primary percutaneous coronary interventions for stent thrombosis Am J Cardiol (2009) 103; 913-6 G. Parodi, G. Memisha, B. Bellandi, R. Valenti, A. Migliorini, N. Carrabba, R. Vergara and D. Antoniucci Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome Am J Cardiol (2008) 101; 1-7 H. Otake, J. Shite, T. Shinke, S. Watanabe, Y. Tanino, D. Ogasawara, T. Sawada, K. Hirata and M. Yokoyama Impact of renal insufficiency on angiographic, procedural, and in-hospital outcomes following percutaneous coronary intervention Am J Cardiol (2008) 101; 780-5 M. D. Osten, J. Ivanov, J. Eichhofer, P. H. Seidelin, J. R. Ross, A. Barolet, E. M. Horlick, D. Ing, L. Schwartz, K. Mackie and V. Dzavik Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study J Am Coll Cardiol (2008) 52; 523-7 P. Ong, A. Athanasiadis, S. Hill, H. Vogelsberg, M. Voehringer and U. Sechtem Xa inhibition and coagulation activity--the influence of prolonged dalteparin treatment and gender in patients with acute coronary syndrome and healthy individuals Am Heart J (2008) 155; 493 e1-8 J. Oldgren, N. Johnston and A. Siegbahn Effect of culprit-lesion remodeling versus plaque rupture on three-year outcome in patients with acute coronary syndrome Am J Cardiol (2009) 103; 791-5 H. Okura, Y. Kobayashi, S. Sumitsuji, M. Terashima, T. Kataoka, M. Masutani, M. Ohyanagi, K. Shimada, H. Taguchi, Y. Yasuga, Y. Takeda, Y. Ohashi, K. Awano, K. Fujii and G. S. Mintz Thrombus aspiration during percutaneous coronary intervention Lancet (2008) 372; 1034; author reply 34-5 J. Oh, N. Hong and S. M. Kang Incremental value of cardiac magnetic resonance imaging in the differential diagnosis of acute coronary syndrome in a young man Eur Heart J (2009) 30; 380 M. Neizel, M. Kelm and H. P. Kuehl A simple prognostic classification model for postprocedural complications after percutaneous coronary intervention for acute myocardial infarction (from the New York State percutaneous coronary intervention database) Am J Cardiol (2009) 103; 937-42 A. Negassa, E. S. Monrad and V. S. Srinivas One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial Eur Heart J (2008) 29; 455-61 G. Ndrepepa, A. Kastrati, J. Mehilli, F. J. Neumann, J. ten Berg, O. Bruskina, F. Dotzer, M. Seyfarth, J. Pache, J. Dirschinger, P. B. Berger and A. Schomig Assessment of patients after coronary artery bypass grafting using 64-slice computed tomography Am J Cardiol (2009) 103; 667-73 I. Nazeri, P. Shahabi, M. Tehrai, B. Sharif-Kashani and A. Nazeri Impact of admission blood glucose on outcomes of nondiabetic patients with acute ST-elevation myocardial infarction (from the German Acute Coronary Syndromes [ACOS] Registry) Am J Cardiol (2009) 103; 583-7 C. K. Naber, R. H. Mehta, C. Junger, U. Zeymer, H. Wienbergen, G. V. Sabin, R. Erbel, J. Senges and A. Gitt Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial Eur Heart J (2008) 29; 2473-9 S. A. Murphy, E. M. Antman, S. D. Wiviott, G. Weerakkody, G. Morocutti, K. Huber, J. Lopez-Sendon, C. H. McCabe and E. Braunwald Hematologic parameters, atherosclerotic progression, and prognosis in patients with previous coronary artery bypass grafting (from the Post CABG Trial) Am J Cardiol (2009) 103; 328-32 K. J. Mukamal, G. A. Wellenius and M. A. Mittleman Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18 Eur Heart J (2008) 29; 1096-102 D. A. Morrow, M. S. Sabatine, M. L. Brennan, J. A. de Lemos, S. A. Murphy, C. T. Ruff, N. Rifai, C. P. Cannon and S. L. Hazen Increased serum levels and expression of S100A8/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina Heart (2008) 94; 1002-7 S. Miyamoto, M. Ueda, M. Ikemoto, T. Naruko, A. Itoh, S. Tamaki, R. Nohara, F. Terasaki, S. Sasayama and M. Fujita Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome Am Heart J (2008) 155; 725-31 L. M. Mielniczuk, M. A. Pfeffer, E. F. Lewis, M. A. Blazing, J. A. de Lemos, A. Shui, S. Mohanavelu, R. M. Califf and E. Braunwald Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIb Eur Heart J (2008) 29; 880-7 R. H. Mehta, S. V. Rao, E. M. Ohman, E. R. Bates, G. Marcucci, M. Zhang, K. S. Pieper, P. W. Armstrong, H. D. White, F. Van de Werf, R. M. Califf and C. B. Granger A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II--study design and rationale Am Heart J (2008) 155; 600-8 R. H. Mehta, J. H. Alexander, R. Emery, S. J. Ellis, V. Hasselblad, A. Khalil, M. Carrier, R. A. Harrington and J. C. Tardif Comparison of outcomes and safety of "facilitated" versus primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction Am J Cardiol (2009) 103; 316-21 R. G. McKay, M. R. Dada, J. F. Mather, R. R. Mennet, D. J. Murphy, K. W. Maloney, J. A. Hirst and F. J. Kiernan Treatment disparities in patients with acute coronary syndromes and kidney disease Eur Heart J (2009) 30; 526-7 P. A. McCullough Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain Am J Cardiol (2009) 103; 22-8 C. J. McCann, B. M. Glover, I. B. Menown, M. J. Moore, J. McEneny, C. G. Owens, B. Smith, P. C. Sharpe, I. S. Young and J. A. Adgey One-year outcomes from the TAXUS express stent versus cypher stent Am J Cardiol (2009) 103; 930-6 M. Mayor, A. Z. Malik, R. J. Minor, Jr., M. C. Deshpande, W. E. Strauss, T. H. Maloney, D. S. Baim, W. O'Neill and D. E. Kandzari Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trial Am J Cardiol (2009) 103; 345-9 M. Maeng, L. O. Jensen, A. M. Galloe, P. Thayssen, E. H. Christiansen, K. N. Hansen, S. Helqvist, H. E. Botker, J. F. Lassen and L. Thuesen High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis Am Heart J (2008) 155; 954-8 A. Lotfi, M. J. Schweiger, G. R. Giugliano, S. A. Murphy and C. P. Cannon Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial Eur Heart J (2008) 29; 1827-33 R. D. Lopes, K. P. Alexander, G. Marcucci, H. D. White, S. Spinler, J. Col, P. E. Aylward, R. M. Califf and K. W. Mahaffey Usefulness of serum cathepsin L as an independent biomarker in patients with coronary heart disease Am J Cardiol (2009) 103; 476-81 Y. Liu, X. Li, D. Peng, Z. Tan, H. Liu, Y. Qing, Y. Xue and G. P. Shi An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents Am J Cardiol (2009) 103; 501-6 J. Liu, A. Maehara, G. S. Mintz, N. J. Weissman, A. Yu, H. Wang, L. Mandinov, J. J. Popma, S. G. Ellis, E. Grube, K. D. Dawkins and G. W. Stone Effect of previous treatment with statins on outcome of patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention Am J Cardiol (2009) 103; 165-9 E. I. Lev, R. Kornowski, H. Vaknin-Assa, I. Ben-Dor, D. Brosh, I. Teplitsky, S. Fuchs, A. Battler and A. Assali Prevalence, prognosis, and implications of isolated minor nonspecific ST-segment and T-wave abnormalities in older adults: Cardiovascular Health Study Circulation (2008) 118; 2790-6 A. Kumar, R. J. Prineas, A. M. Arnold, B. M. Psaty, C. D. Furberg, J. Robbins and D. M. Lloyd-Jones Three-year survival following multivessel percutaneous coronary intervention with bare-metal or drug-eluting stents in unselected patients Am J Cardiol (2009) 103; 203-11 N. Kukreja, Y. Onuma, H. M. Garcia-Garcia, J. Daemen, R. van Domburg and P. W. Serruys Combined prognostic utility of white blood cell count, plasma glucose, and glomerular filtration rate in patients undergoing primary stent placement for acute myocardial infarction Am J Cardiol (2009) 103; 322-7 M. Kosuge, K. Kimura, S. Morita, S. Kojima, T. Sakamoto, M. Ishihara, Y. Asada, C. Tei, S. Miyazaki, M. Sonoda, K. Tsuchihashi, M. Yamagishi, M. Shirai, H. Hiraoka, T. Honda, Y. Ogata and H. Ogawa Intravenous administration of nicorandil immediately before percutaneous coronary intervention can prevent slow coronary flow phenomenon Heart J (2009) 30; 765-72 Y. Kawai, K. Hisamatsu, H. Matsubara, K. Dan, S. Akagi, K. Miyaji, M. Munemasa, Y. Fujimoto, K. F. Kusano and T. Ohe Eur Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk Am Heart J (2009) 157; 502-8 C. D. Joyner, R. J. Peters, R. Afzal, S. Chrolavicius, S. R. Mehta, K. A. Fox, C. B. Granger, M. G. Franzosi, M. Flather, A. Budaj, J. P. Bassand and S. Yusuf Guidelines for the diagnosis and treatment of non-ST segment elevation acute coronary syndromes Eur Heart J (2008) 29; 277 O. M. Jolobe ST resolution 1 hour after fibrinolysis for prediction of myocardial infarct size: insights from ASSENT 3 Am J Cardiol (2009) 103; 154-8 P. Johanson, Y. Fu, G. S. Wagner, S. G. Goodman, C. B. Granger, L. Wallentin, F. Van de Werf and P. W. Armstrong Paclitaxel-eluting stent long-term outcomes in percutaneous saphenous vein graft interventions (PELOPS) study Am J Cardiol (2009) 103; 199-202 M. H. Jim, H. H. Ho, R. L. Ko, K. H. Yiu, C. W. Siu, C. P. Lau and W. H. Chow Sleep quality and elevated blood pressure in adolescents Circulation (2008) 118; 1034-40 S. Javaheri, A. Storfer-Isser, C. L. Rosen and S. Redline Prognostic value of circulating chromogranin A levels in acute coronary syndromes Eur Heart J (2009) 30; 25-32 A. M. Jansson, H. Rosjo, T. Omland, T. Karlsson, M. Hartford, A. Flyvbjerg and K. Caidahl Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial Am Heart J (2009) 157; 599-605 S. James, A. Akerblom, C. P. Cannon, H. Emanuelsson, S. Husted, H. Katus, A. Skene, P. G. Steg, R. F. Storey, R. Harrington, R. Becker and L. Wallentin Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome: a virtual histology-intravascular ultrasound analysis Eur Heart J (2009) Y. J. Hong, M. H. Jeong, Y. H. Choi, J. S. Ko, M. G. Lee, W. Y. Kang, S. E. Lee, S. H. Kim, K. H. Park, D. S. Sim, N. S. Yoon, H. J. Youn, K. H. Kim, H. W. Park, J. H. Kim, Y. Ahn, J. G. Cho, J. C. Park and J. C. Kang A three-vessel virtual histology intravascular ultrasound analysis of frequency and distribution of thin-cap fibroatheromas in patients with acute coronary syndrome or stable angina pectoris Am J Cardiol (2008) 101; 568-72 M. K. Hong, G. S. Mintz, C. W. Lee, J. W. Lee, J. H. Park, D. W. Park, S. W. Lee, Y. H. Kim, S. S. Cheong, J. J. Kim, S. W. Park and S. J. Park Percutaneous coronary intervention versus coronary artery bypass grafting as primary revascularization in patients with acute coronary syndrome Am J Cardiol (2008) 102; 173-9 W. Hochholzer, H. J. Buettner, D. Trenk, T. Breidthardt, M. Noveanu, K. Laule, M. Christ, C. Schindler, F. J. Neumann and C. Mueller Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias Eur Heart J (2009) 30; 645-54 A. Hirsch, F. Windhausen, J. G. Tijssen, A. J. Oude Ophuis, W. J. van der Giessen, P. M. van der Zee, J. H. Cornel, F. W. Verheugt and R. J. de Winter The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial Heart (2008) 94; 717-23 M. Henriksson, D. M. Epstein, S. J. Palmer, M. J. Sculpher, T. C. Clayton, S. J. Pocock, R. A. Henderson, M. J. Buxton and K. A. Fox Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention Am J Cardiol (2009) 103; 779-84 A. K. Hassan, S. C. Bergheanu, H. Hasan-Ali, S. S. Liem, A. van der Laarse, R. Wolterbeek, D. E. Atsma, M. J. Schalij and J. W. Jukema Comparison of treatment and outcome of acute coronary syndrome in patients with versus patients without diabetes mellitus Am J Cardiol (2009) 103; 772-8 T. Hasin, M. Hochadel, A. K. Gitt, S. Behar, H. Bueno and Y. Hasin Comparison of long-term efficacy of the paclitaxel-eluting stent versus the bare-metal stent for treatment of unprotected left main coronary artery disease Am J Cardiol (2009) 103; 194-8 Y. Han, S. Wang, Q. Jing, Y. Li, H. Liu, Y. Ma, Z. Wang, D. Wang, B. Luan, G. Wang and T. Chen Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study Am Heart J (2009) 157; 733-9 Y. Han, Y. Li, S. Wang, Q. Jing, Z. Wang, D. Wang, Q. Shu and X. Tang The perfect biomarker in acute coronary syndrome: a challenge for diagnosis, prognosis, and treatment Eur Heart J (2008) 29; 2827-8 J. Gravning and J. Kjekshus Usefulness of serum high-density lipoprotein cholesterol level as an independent predictor of one-year mortality after percutaneous coronary interventions Am J Cardiol (2009) 103; 902-6 Z. B. Ghazzal, S. S. Dhawan, A. Sheikh, J. S. Douglas, E. Veledar, K. Mavromatis, F. K. Pohlel and V. Vaccarino Ensuring appropriate use of antiplatelet agents in the treatment of acute coronary syndromes--have cardiovascular physicians been given enough grace in getting it right? Heart (2008) 94; 135-7 A. H. Gershlick Residual platelet activity is increased in clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease Heart (2008) 94; 743-7 T. Geisler, M. Kapp, K. Gohring-Frischholz, K. Daub, C. Dosch, B. Bigalke, H. Langer, C. Herdeg and M. Gawaz Ten-year all-cause mortality in presumably healthy subjects on lipid-lowering drugs (from the Prospective Epidemiological Study of Myocardial Infarction [PRIME] prospective cohort) Am J Cardiol (2009) 103; 381-6 V. Gardette, V. Bongard, J. Dallongeville, D. Arveiler, A. Bingham, J. B. Ruidavets, P. Amouyel, B. Haas, P. Ducimetiere and J. Ferrieres Racial disparities in outcomes following percutaneous coronary intervention with drug-eluting stents Am J Cardiol (2009) 103; 653-8 M. A. Gaglia, Jr., D. H. Steinberg, T. L. Pinto Slottow, P. K. Roy, L. Bonello, A. Delabriolle, G. Lemesle, T. Okabe, R. Torguson, K. Kaneshige, Z. Xue, W. O. Suddath, K. M. Kent, L. F. Satler, A. D. Pichard, J. Lindsay and R. Waksman Guidelines for anticoagulant use in acute coronary syndromes Lancet (2008) 371; 1559-61 J. Eikelboom, G. Guyatt and J. Hirsh Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome Am Heart J (2008) 156; 588-94 K. M. Eggers, B. Lagerqvist, J. Oldgren, P. Venge, L. Wallentin and B. Lindahl Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture Am J Cardiol (2009) 103; 818-23 H. Doi, A. Maehara, G. S. Mintz, K. Tsujita, T. Kubo, C. Castellanos, J. Liu, J. Yang, C. Oviedo, J. Aoki, T. Franklin-Bond, N. Dasgupta, A. J. Lansky, G. D. Dangas, G. W. Stone, J. W. Moses, R. Mehran and M. B. Leon Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events Eur Heart J (2008) 29; 1275-82 G. Devlin, J. M. Gore, J. Elliott, N. Wijesinghe, K. A. Eagle, A. Avezum, W. Huang and D. Brieger Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery Am J Cardiol (2009) 103; 639-45 A. De Labriolle, G. Lemesle, L. Bonello, A. I. Syed, S. D. Collins, I. Ben-Dor, T. L. Pinto Slottow, Z. Xue, R. Torguson, W. O. Suddath, L. F. Satler, K. M. Kent, A. D. Pichard, J. Lindsay and R. Waksman Evaluating risks and benefits in coronary revascularisation--a very imperfect art? Heart (2009) 95; 6-8 M. A. de Belder and L. Hamilton Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes Heart (2008) 94; 159-65 O. H. Dabbous, F. A. Anderson, Jr., J. M. Gore, K. A. Eagle, K. A. Fox, R. H. Mehta, R. J. Goldberg, G. Agnelli and P. G. Steg Usefulness of coronary fractional flow reserve measurements in guiding clinical decisions in intermediate or equivocal left main coronary stenoses Am J Cardiol (2009) 103; 943-9 J. Courtis, J. Rodes-Cabau, E. Larose, J. M. Potvin, J. P. Dery, R. D. Larochelliere, M. Cote, O. Cousterousse, C. M. Nguyen, G. Proulx, S. Rinfret and O. F. Bertrand Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predict Am Heart J (2008) 155; 841-7 D. P. Chew, K. W. Mahaffey, H. D. White, Z. Huang, J. W. Hoekstra, J. J. Ferguson, R. M. Califf and P. E. Aylward Left ventricular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health Study Circulation (2008) 117; 2599-607 H. A. Chami, R. B. Devereux, J. S. Gottdiener, R. Mehra, M. J. Roman, E. J. Benjamin and D. J. Gottlieb Stunning, hibernation, and assessment of myocardial viability Circulation (2008) 117; 103-14 P. G. Camici, S. K. Prasad and O. E. Rimoldi Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes Eur Heart J (2009) 30; 655-61 A. Budaj, J. W. Eikelboom, S. R. Mehta, R. Afzal, S. Chrolavicius, J. P. Bassand, K. A. Fox, L. Wallentin, R. J. Peters, C. B. Granger, C. D. Joyner and S. Yusuf Relation of periprocedural bleeding complications and long-term outcome in patients undergoing percutaneous coronary revascularization (from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial) Am J Cardiol (2009) 103; 917-22 J. J. Brugts, N. Mercado, S. Hu, M. Guarneri, M. Price, R. Schatz, P. Teirstein, W. Wijns, P. W. Serruys, W. W. O'Neill and E. Boersma Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial Am Heart J (2008) 155; 1039-46 M. A. Brouwer, P. C. Kievit, H. J. Dieker, G. Veen, A. J. Karreman and F. W. Verheugt Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes. The Global Registry of Acute Coronary Events Heart (2009) D. Brieger, K. A. Fox, G. Fitzgerald, K. A. Eagle, A. Budaj, A. Avezum, C. B. Granger, B. Costa, F. A. Anderson and P. G. Steg Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report Am Heart J (2008) 155; 140-6 S. J. Brener, S. Milford-Beland, M. T. Roe, D. L. Bhatt, W. S. Weintraub and R. G. Brindis Predictors of infarct artery patency after prehospital thrombolysis. The multicentre, prospective, observational OPTIMAL study Heart (2008) V. Bongard, J. Puel, D. Savary, L. Belle, S. Charpentier, Y. Cottin, L. Soulat, M. Elbaz, D. Miljkovic and P. G. Steg Thrombus aspiration during percutaneous coronary intervention Lancet (2008) 372; 1034; author reply 34-5 L. Bonello, A. De Labriolle, D. Steinberg and R. Waksman Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries Am J Cardiol (2009) 103; 496-500 L. Bonello, A. De Labriolle, G. Lemesle, P. Roy, D. H. Steinberg, T. L. Slottow, Z. Xue, R. Torguson, K. Kaneshige, W. O. Suddath, L. F. Satler, K. M. Kent, J. Lindsay, A. D. Pichard and R. Waksman Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis Am J Cardiol (2009) 103; 5-10 L. Bonello, L. Camoin-Jau, S. Armero, O. Com, S. Arques, C. Burignat-Bonello, M. P. Giacomoni, R. Bonello, F. Collet, P. Rossi, P. Barragan, F. Dignat-George and F. Paganelli Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome Am Heart J (2008) 156; 193-200 B. Bigalke, T. Geisler, K. Stellos, H. Langer, K. Daub, E. Kremmer, P. Seizer, A. E. May, S. Lindemann and M. Gawaz Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study Am Heart J (2009) 157; 509-16 e1 Y. Bi, R. Gao, A. Patel, S. Su, W. Gao, D. Hu, D. Huang, L. Kong, W. Qi, Y. Wu, Y. Yang and F. Turnbull Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes Eur Heart J (2009) D. L. Bhatt, E. D. Peterson, R. A. Harrington, F. S. Ou, C. P. Cannon, C. M. Gibson, N. S. Kleiman, R. G. Brindis, W. F. Peacock, S. J. Brener, V. Menon, S. C. Smith, Jr., C. V. Pollack, Jr., W. B. Gibler, E. M. Ohman and M. T. Roe Non-ST-segment elevation acute coronary syndromes: an algorithm for decision Eur Heart J (2008) 29; 279-80 M. E. Bertrand, J. P. Collet and G. Montalescot Presence and extent of coronary artery disease by cardiac computed tomography and risk for acute coronary syndrome in cocaine users among patients with chest pain Am J Cardiol (2009) 103; 620-5 F. Bamberg, C. L. Schlett, Q. A. Truong, I. S. Rogers, W. Koenig, J. T. Nagurney, S. Seneviratne, S. J. Lehman, R. C. Cury, S. Abbara, J. Butler, H. Lee, T. J. Brady and U. Hoffmann Acute coronary syndrome following a recent Bentall-De Bono procedure Eur Heart J (2009) 30; 627 A. Auricchio, F. Faletra and T. Moccetti Acute and stable coronary heart disease: different risk factors Eur Heart J (2008) 29; 1927-9 S. Agewall